Alan
Provides digital health insurance and prevention-focused healthcare services for European employers and their workforces.
Overview
Alan is a European healthcare company focused on prevention-oriented insurance, positioning itself as a potential healthcare platform for the region. Its offering targets employers and members seeking health coverage tied to more proactive care. The company’s differentiation centers on combining insurance with preventive health services rather than only reimbursing care after illness. Prosus invested $460 million in an undisclosed round valuing Alan at $6.3 billion, bringing total disclosed funding to $460 million.
Funding History
Prosus pours $460M into Alan at $6.3B: Can prevention insurance become Europe’s next healthcare giant?
Frequently Asked Questions
- How much has Alan raised in total?
- Alan has raised a total of $460M across 1 funding round.
- Who are Alan's investors?
- Alan's investors include Undisclosed.
- What does Alan do?
- Alan is a European healthcare company focused on prevention-oriented insurance, positioning itself as a potential healthcare platform for the region. Its offering targets employers and members seeking health coverage tied to more proactive care. The company’s differentiation centers on combining insurance with preventive health services rather than only reimbursing care after illness. Prosus invested $460 million in an undisclosed round valuing Alan at $6.3 billion, bringing total disclosed funding to $460 million.
- Where is Alan headquartered?
- Alan is headquartered in Europe.
Investors
Related Insights
A comprehensive analysis of ChipAgents's funding history, investors, competitive position, and growth trajectory in the AI Developer Tools space.
An in-depth analysis of 8090 Industries's AI investment portfolio, strategy, co-investors, and sector focus across 1 tracked deals.
An in-depth analysis of Aker ASA's AI investment portfolio, strategy, co-investors, and sector focus across 2 tracked deals.